cisapride has been researched along with MS (Multiple Sclerosis) in 2 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Read, SJ | 1 |
Leggett, BA | 1 |
Pender, MP | 1 |
König, B | 1 |
2 other studies available for cisapride and MS (Multiple Sclerosis)
Article | Year |
---|---|
Gastroparesis with multiple sclerosis.
Topics: Cisapride; Female; Gastric Emptying; Gastroparesis; Humans; Middle Aged; Multiple Sclerosis; Parasym | 1995 |
[Prokinetic drug more effective than laxatives. Despite multiple sclerosis, no enema].
Topics: Adult; Cisapride; Constipation; Dose-Response Relationship, Drug; Drug Administration Schedule; Fema | 1998 |